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Tumor necrosis factor a converting enzyme
Tumor necrosis factor aa b s t r a c t
Tumor necrosis factor a (TNFa) is an inﬂammatory cytokine that plays an intimate role in septic
shock. Injection of high levels of lipopolysaccharide induces septic shock and death in mice within
30 h, whereas ceramide synthase 2 (CerS2) null mice, defective in the synthesis of very-long acyl
chain ceramides, die within 10 h. The augmented rate of death of CerS2 null mice is due to elevated
levels of TNFa secretion as a result of enhanced activity of TNFa-converting enzyme (TACE). We
discuss the relationship between the sphingolipid acyl chain length and TACE activity and the
relevance of this data to septic shock.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction rates of hepatocyte death and proliferation, resulting in formationDue to its potent polytrophic effects on survival, apoptosis, and
necroptosis, tumor necrosis factor a (TNFa) secretion is tightly
regulated [1]. Mis-regulation of TNFa secretion has been linked
to various diseases and pathologies including sepsis, rheumatoid
arthritis and cancer [2]. In mice, TNFa mRNA is translated into a
26kDa precursor protein (pro-TNFa) which is transported to the
plasma membrane where it resides as a type II membrane protein
[3]. The pro-TNFa ecto-domain is cleaved by TNFa-converting
enzyme (TACE) prior to its release as a biologically-active 17kDa
soluble form [4,5].
We now examine the effect of altering the ceramide/sphin-
golipid (SL) acyl chain length on TNFa secretion and TACE activity
in a model of sepsis. This study was performed using ceramide syn-
thase 2 (CerS) null mice, which are unable to generate very-long
chain (C22–C24) ceramides [6,7]. CerS2 null mice display increasedof multiple hepatic nodules, and in some cases, hepatocellular car-
cinoma [7], along with chronic oxidative stress [8] and hepatic
insulin resistance [9], which are all likely due to changes in mem-
brane biophysical properties [10]. Recently, we demonstrated that
altering the SL acyl chain composition in CerS2 null mice prevents
lipopolysaccharide (LPS)/galactosamine (GLN)-mediated hepatic
failure by disrupting TNFR1 internalization [11]. We now show
that in an LPS-induced model of sepsis, CerS2 null mice secrete
high levels of TNFa due to enhanced TACE activity, which results
in rapid death of the animals upon LPS-mediated septic shock.
2. Materials and methods
2.1. Reagents
A rabbit polyclonal anti-TACE antibody was from Abcam
(Cambridge, UK). LPS was from Sigma–Aldrich (St. Louis, MO,
USA). TACE substrates were from R&D (Minneapolis, MN, USA). A
TNFa ELISA kit was from Biolegend (San Diego, CA). Macrophage
colony stimulating factor was from Peprotech (Rocky Hill, NJ).
2.2. Mice
CerS2 null mice were generated and maintained as described
[11]. Mice were treated in accordance with the Animal Care
Fig. 1. Sensitivity of Cers2 null mice to LPS-mediated septic shock. 2–3 month-old
WT and CerS2 null mice were injected intraperitoneally with a single dose of LPS
(35 mg/kg) and the survival of the mice was determined. n = 9.
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Committee, and the National Institutes of Health’s Guidelines for
Animal Care. Mice were injected intraperitoneally with 35 mg/kg
LPS. Liver sections were collected for histological examination or
were ﬂash frozen. Blood was collected via the orbital sinus for anal-
ysis of TNFa secretion. Serum TNFa levels were measured using an
anti-mouse enzyme-linked immunosorbent assay kit (BioLegend,
San Diego, CA).
2.3. Hepatocyte isolation
Hepatocytes were isolated from mice after hepatic portal vein
perfusion using warm Ca++- and Mg++-free Hank’s balanced salt
solution (Sigma–Aldrich) containing 5.5 mM KCl, 5.5 mM glucose,
25 mM NaHCO3, 0.7 mM EDTA for 3 min, to which liver digest
media (GIBCO/BRL Life Technologies, Carlsbad, CA, U.S.A) was
added for a further 8 min. After perfusion, the liver was quickly
excised and the gall bladder removed. Hepatocytes were separated
from connective tissue using sterile tweezers and then passed
through a cell strainer (BD Falcon Labware, Franklin Lakes, NJ
USA) and centrifuged at 50  gav (4 C, 5 min). Hepatocytes were
suspended in DMEM containing 10% fetal bovine serum, 2 mM
sodium pyruvate, 2% penicillin/streptomycin and 1 lM
dexamethasone.
2.4. Isolation of bone marrow derived macrophages
2–3 month-old mice were euthanized and the tibia and ﬁbula
collected for the extraction of bone marrow. Bone marrow cells
were cultured in RPMI medium (Gibco, Invitrogen, USA) supple-
mented with 15% fetal bovine serum, 1% sodium pyruvate, 1% peni-
cillin/streptomycin and 10 ng/ml macrophage colony stimulating
factor, and cultured for 7 days [12]. Bone marrow-derived macro-
phage (BMDMs) were serum-starved for 5–8 h.
2.5. Western blotting
Tissue lysates were prepared in radioimmunoprecipitation
assay buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% Nonidet P-40,
0.5% sodium deoxycholate, 0.1% SDS) containing 50 mM NaF and
2 mM Na3VO4. Protein was measured using the BCA Protein
Assay Kit (Pierce Chemical Co., Carlsbad, CA, USA). Fifty microgram
of protein was loaded and separated on 8–15% SDS–PAGE and
transferred to a nitrocellulose or PVDF membrane. The membrane
was blocked using 5% bovine serum albumin in
phosphate-buffered saline containing 0.1% Tween-20 (PBST) for
1 h at room temperature. The primary antibody was diluted in
PBST containing 1% bovine serum albumin and incubated with
the membrane at 4 C overnight. After 3 washes with PBST, mem-
branes were incubated with the secondary antibody in PBST con-
taining 1% BSA at room temperature for 1 h.
2.6. Quantitative real-time PCR
Total RNA was isolated using the RNeasy mini kit (Qiagen,
Venlo, The Netherlands) according to manufacturer’s instructions.
cDNA synthesis was performed using a Reverse-iT ﬁrst strand
synthesis kit (Thermo Scientiﬁc, Grand Island, NY, USA) using
random hexamers. qPCR was performed using a SYBR Green
PCR Master Mix (Finnzyme, Life Technologies, Vantaa, Finland)
with cDNA (equivalent to 5 ng of total RNA) and an ABI Prism
7000 Sequence Detection System (Applied Biosystems, Life
Technologies).The following primers were used:IjBa: Forward: TTGGTCAGGTGAAGGGAGAC;
Reverse: ACAGCCAAGTGGAGTGGAGT.A20: Forward: GGTGATGGAAACTGCCTCAT;
Reverse: CTTCCTCAGGACCAGGTCAG.cIAP2: Forward: CGAGGAGGAGGAGTCAGATG;
Reverse: GGAGGCAATACAGCATTGGT.TNFa: Forward: CTTGTGGCAGGGGCCACCAC;
Reverse: CCATGCCGTTGGCCAGGAG.2.7. Confocal microscopy
Confocal microscopy was performed using an Olympus IX 81
Fluo-View 1000 microscope and a UPLSAPO 60 objective.
2.8. Statistical analysis
Values are expressed as means ± S.E.M. Statistical signiﬁcance
was calculated using the Student’s t test.
3. Results and discussion
Injection of high doses of LPS (35 mg/kg) lead to the death of
WT mice within 30 h whereas CerS2 null mice died within 10 h,
with a mean time of death of 5.4 ± 4.3 h compared to 17.7 ± 4.8 h
in WT mice (Fig 1). LPS treatment causes secretion of TNFa which
leads to secretion of proinﬂammatory cytokines (the ‘cytokine
storm’) resulting in sepsis [13]. TNFa levels in serum from CerS2
null mice were 6-fold higher than in WT mice 1.5 and 3 h after
LPS treatment (Fig. 2).
To determine whether increased levels of serum TNFa might
result from increased secretion from macrophages, bone marrow
cells were treated with macrophage colony stimulating factor to
differentiate them into bone marrow-derived macrophages
(BMDMs) [12], followed by treatment with 200 ng/ml LPS.
BMDMs from CerS2 null mice secreted higher amounts of TNFa
than BMDMs from WT mice (Fig. 3A); however, there was no
change in levels of TNFa mRNA (Fig. 3B) or protein (not shown),
no changes in TLR4 activation as estimated by ERK1/2 phosphory-
lation (not shown), and no changes in levels of expression of genes
Fig. 2. Serum TNFa levels after LPS treatment. Serum TNFa levels were measured at
1.5 and 3 h after LPS treatment (as in Fig 1). n = 5, *P < 0.05, **P < 0.005.
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These results are consistent with altered TNFa levels being a result
of altered TNFa processing. Indeed, TACE activity was signiﬁcantly
elevated in BMDMs (Fig. 4A), without any change in intracellular
distribution of TACE (Fig. 4B). TACE activity was also elevated in
CerS2 null liver (6.3 ± 1.4 lmol/mg/min in CerS2 null liver com-
pared to 3.4 ± 0.3 lmol/mg/min in WT liver; n = 4) and in hepato-
cytes isolated from CerS2 null (1.86 ± 0.15 lmol/mg/min)
compared to WT mice (1.14 ± 0.27 lmol/mg/min; n = 4), which
corresponded with increased levels of TNFa secretion both before
and after treatment with 500 ng/ml LPS (Fig. 5A). However, levels
of TACE protein were unaltered (Fig. 5B), conﬁrming the notion
that TACE activity is modulated via a post-translational mecha-
nism, which is presumably related to the altered SL acyl chain
length.Fig. 3. TNFa secretion from BMDMs. BMDMs were incubated with 200 ng/ml LPS. (A) TN
in BMDMs. n = 4, *P < 0.05.Previously we demonstrated that CerS2 null mice were pro-
tected against LPS/GLN-mediated fulminant hepatic failure due to
disrupted TNFR1 internalization,which resulted in inhibition of cas-
pase 8 activation. However, TNFR1-mediated NFjB signaling is not
altered in CerS2 null mice [11], which is consistent with activation
of NFjB inﬂammatory pathways [14] due to excessive TNFa
secretion. Although we did not determine the precise mechanistic
relationship between the SL acyl chain length and TACE activity, a
number of possibilities could explain our results. TACE is negatively
regulated by tissue inhibitor of metalloproteinase 3 (TIMP3), a
25kDa secreted protein that interacts strongly with the
extra-cellular matrix [15,16]. TIMP3/ mice exhibit high levels of
TACE activity and as a result secrete elevated levels of TNFa, which
results in liver necrosis and liver failure [17,18]; indeed, CerS2 null
mice show a 45 ± 14% (n = 6) reduction in levels of TIMP3 in the
liver. Previous studies have shown that altering the SL composition
directly affects TACE activity; thus, TACE is hyper-activated in acid
sphingomyelinase / cells, and exogenously-added acid sphin-
gomyelinase inhibits TACE activity, as does exogenously-added
short acyl chain ceramide [19]. Moreover, ceramide 1-phosphate
binds TACE directly and down-regulates its activity [20], although
this is unlikely to be the mechanism involved in TACE regulation
in the current study as ceramide 1-phosphate levels are essentially
unchanged (data not shown). Thus, there is signiﬁcant evidence that
altering the SL composition, and in particular ceramide levels, can
modulate TACE activity; our study suggests that altering the SL acyl
chain length increases TACE activity although whether this is speci-
ﬁc to the changes in the SL composition observed in CerS2 null
mouse, or might occur in other CerS null mice, is currently
unknown. Importantly, TACE is regulated by membrane compo-
nents, with lipid raft depletion resulting in elevated TACE activity
[21], and lipid rafts are disrupted in CerS2 null mice (as ascertained
by changes in cholera toxin binding [9]); it is possible that TIMP3 is
unable to interactwith TACE in lipid rafts. Irrespective of the precise
mechanism by which TACE activity is elevated in CerS2 null mice,
our study indicates a direct link between SL composition and
TACE activation, which may impact upon processes in which TACE
is involved such as sepsis, inﬂammation and cell tumorogenesis.Fa levels in the medium. n = 5, *P < 0.05, **P < 0.005. (B) TNFa and IjBamRNA levels
Fig. 4. TACE activity and intracellular localization. (A) TACE activity was measured in BMDMs from WT and CerS2 null mice. n = 4, *P < 0.05. (B) TACE localization (red)
detected by confocal microscopy; blue (DAPI) indicates nuclei. Scale bar, 20 lm.
Fig. 5. (A) TNFa secretion and levels in hepatocytes and liver. (A) Black columns show basal TNFa levels and gray columns show TNFa levels 60 min after LPS (500 ng/ml)
treatment. n = 3, *P < 0.005. (B) Western blot of TACE in liver homogenates. The different forms of TACE are identiﬁed. The experiment was repeated 5 times and gave similar
result.
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